Advertisement

Topics

Vacsera Biological Products & Vaccines Holding Company Company Profile

04:46 EDT 28th July 2017 | BioPortfolio

On behalf of all of our staff members, we welcome you to our Web site. Here you will learn more about our corporate vision , values , goals ,products
and services as well as our affiliated companies.

Vacsera is the leading company in the field of biological products &vaccines
manufacturing in Egypt and the Middle East.

We are focused on pursuing strategic investment opportunities in a number
of sectors within the pharmaceutical and biopharmaceutical industries.

These include research and development, manufacturing, distribution, and intellectual property acquisitions.

Location

51 Wizaret El-Zeraa - Agouza
Giza
22311
Egypt

Contact

Phone: (202) 76 111 11
Fax: (202) 33 698 72
Email: ceo@vacsera.com


News Articles [5131 Associated News Articles listed on BioPortfolio]

Biological E. In-licenses Two Takeda Vaccines for India/China

India's Biological E. Limited in-licensed rights to two Takeda vaccines for India, China and low/middle income countries. Biological E intends to combine the vaccines, which protect against measles an...

Takeda and Biological E. collaborate to develop affordable combination vaccines

Japanese pharmaceutical company Takeda has entered two licensing agreements with Indian firm Biological E. to accelerate the development and supply of low-cost combination vaccines.

Takeda and Biological E. Limited Announce Partnership to Develop Low-Cost Combination Vaccines ...

Two recently-signed agreements will transfer Takeda’s measles and acellular pertussis vaccine technologies to India-based multi-national company Biological E. Limited (“BE”) to dev...

Global Animal Vaccines by Product Type Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, and DNA Vaccines and Animal Type [Companion animals Dogs, Cats, and Others, Cattle, Pigs, Poultr

Veterinary vaccines are used for prevention of diseases that affect animals. Animal vaccination is a costeffective solution to maintain animal health and sustainability, offering various benefits such...

China Human Vaccine Industry Report, 2017-2021

LONDON, July 24, 2017 /PRNewswire/ -- The human vaccine industry presented the following main characteristics in 2016 in China:1. Lot release volume of human vaccines declined.Affected by the illegal ...

China Biologic to Attend Jefferies Healthcare Conference on September 27 and 28, 2011 in London

BEIJING, Sept. 26, 2011 /PRNewswire-Asia-FirstCall/ China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the ...

Takeda's measles, pertussis vaccines licensed to Biological E.

Takeda licensed its measles and pertussis vaccines to Biological E. to allow Biological E.  -More- 

Middle East and Africa Veterinary Vaccines Market Segmented By Animal Type, Technology and By Country Industry Analysis, Market Size, Extensive Company Shares, Growth Trends and YOY Forecasts 20162021 [Updated: 01012017] Prices from USD $2875

The MiddleEast Africa animal vaccines market is poised to reach $541.4 Million by 2021 from $389.6 Million in 2016, at a CAGR of 6.8% from 2016 to 2021. Veterinary Vaccines are important and, at tim...

PubMed Articles [2773 Associated PubMed Articles listed on BioPortfolio]

The European Regulatory Environment of RNA-Based Vaccines.

A variety of different mRNA-based drugs are currently in development. This became possible, since major breakthroughs in RNA research during the last decades allowed impressive improvements of transla...

Fluorescent natural products as probes and tracers in biology.

Covering: 1985 up to the end of 2016Fluorescence is a remarkable property of many natural products in addition to their medicinal and biological values. Herein, we provide a review on these peculiar s...

Status of the development of a vaccine against Mycoplasma bovis.

Mycoplasma bovis is an important pathogen of cattle and, despite numerous efforts an effective vaccine for control of the disease it causes remains elusive. Although we now know more about the biology...

Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000.

The approval, from 1986, of a series of recombinant hepatitis B vaccines was a landmark both in the growth of biotechnology and in the development of the vaccine innovation system. In this paper, we s...

Introduction to RNA Vaccines.

RNA vaccines are attractive, because they exhibit characteristics of subunit vaccines and live-attenuated vectors, including flexible production and induction of both humoral and cellular immunity. Wh...

Clinical Trials [2947 Associated Clinical Trials listed on BioPortfolio]

Energy Cost for Holding a MedGem® Indirect Calorimeter

The goal of this clinical protocol is to perform a randomized crossover study to determine the energy cost of holding the MedGem® device above a person's normal resting metabolic rate (RM...

Immunogenicity and Safety of Kinrix + MMR With and Without Varicella Vaccine in Healthy Children 4-6 Years

The purpose of the study is to evaluate the immunogenicity and safety of Kinrix when co-administered with varicella (Varivax® [varicella virus vaccine live], Merck and Company) and MMR va...

Kangaroo Holding Effects on Breast Milk

Kangaroo holding is a skin-to-skin method of holding a baby. Many research studies have investigated the maternal and infant benefits associated with kangaroo holding. The purpose of thi...

Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age

The purpose of this study is to compare two measles, mumps and rubella conjugate vaccines (manufactured by GSK and Merck and Company ) in terms of the immune response elicited and safety w...

Kangaroo Holding and Maternal Stress

The primary objective is to determine if kangaroo holding in the first week after birth influences the stress levels of mothers who have delivered their infants prematurely and who require...

Companies [3805 Associated Companies listed on BioPortfolio]

Vacsera Biological Products & Vaccines Holding Company

On behalf of all of our staff members, we welcome you to our Web site. Here you will learn more about our corporate vision , values , goals ,productsand services as well as our affiliated companies.Va...

ASCIInc

ASCIInc is a premiere Healthcare and Life Science Company that understands the labyrinth of possibilities involving immunization and vaccination programs utilizes an intelligent eidetic system includi...

Biological E Limited

Humanity has come a long way. With gradual effort, today we are in a position to prevent major life-threatening illnesses. However the quest for healthy life is an ever-lasting journey. Biological E. ...

Embrex Incorporated

Embrex, Inc. develops and markets biological delivery technology and biological products to increase the productivity andprofitability of the global poultry industry. Embrex has developed and commerci...

Avant Immunotherapeutics

AVANT Immunotherapeutics, Inc. is engaged in the discovery, development and commercialization of products that harness the human immune system to prevent and treat disease. The company is developing a...

More Information about "Vacsera Biological Products & Vaccines Holding Company" on BioPortfolio

We have published hundreds of Vacsera Biological Products & Vaccines Holding Company news stories on BioPortfolio along with dozens of Vacsera Biological Products & Vaccines Holding Company Clinical Trials and PubMed Articles about Vacsera Biological Products & Vaccines Holding Company for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vacsera Biological Products & Vaccines Holding Company Companies in our database. You can also find out about relevant Vacsera Biological Products & Vaccines Holding Company Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record